Soligenix Invited to Present at Upcoming Investor Conferences

PRINCETON, N.J., Oct. 16, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Company will be providing a corporate update at the upcoming investor conferences on the dates below. 2024 Maxim Healthcare Virtual Summit, held October 17, 2024. For more information, please refer to the conference website https: ...